Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/22762
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2021-11-22T13:19:09Z-
dc.date.available2021-11-22T13:19:09Z-
dc.date.issued2006-
dc.identifier.citationErsoy, A. vd. (2006). ''Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus''. Nephrology Dialysis Transplantation, 21(2), 553-554.en_US
dc.identifier.issn0931-0509-
dc.identifier.urihttps://doi.org/10.1093/ndt/gfi205-
dc.identifier.urihttps://academic.oup.com/ndt/article/21/2/553/1850702-
dc.identifier.urihttp://hdl.handle.net/11452/22762-
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectTransplantationen_US
dc.subjectUrology & nephrologyen_US
dc.subjectTherapyen_US
dc.subject.meshRenal dialysisen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshDiabetes mellitus, type 2en_US
dc.subject.meshFailure, chronicen_US
dc.subject.meshKidneyen_US
dc.subject.meshInsulinen_US
dc.subject.meshHypoglycemic agentsen_US
dc.subject.meshHumansen_US
dc.subject.meshFemaleen_US
dc.titleInsulin analogue usage in a haemodialysis patient with type 2 diabetes mellitusen_US
dc.typeArticleen_US
dc.identifier.wos000234782900057tr_TR
dc.identifier.scopus2-s2.0-31544464630tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Nefroloji ve Diyaliz Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Endokrinoloji ve Metabolizma Bölümü.tr_TR
dc.contributor.orcid0000-0002-0710-0923tr_TR
dc.identifier.startpage553tr_TR
dc.identifier.endpage554tr_TR
dc.identifier.volume21tr_TR
dc.identifier.issue2tr_TR
dc.relation.journalNephrology Dialysis Transplantationen_US
dc.contributor.buuauthorErsoy, Alpaslan-
dc.contributor.buuauthorErsoy, Canan-
dc.contributor.buuauthorAltınay, Tumay-
dc.contributor.researcheridAAH-8861-2021tr_TR
dc.contributor.researcheridAAH-5054-2021tr_TR
dc.identifier.pubmed16221693tr_TR
dc.subject.wosTransplantationen_US
dc.subject.wosUrology & nephrologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubmeden_US
dc.wos.quartileQ1 (Urology & nephrology)en_US
dc.wos.quartileQ2 (Transplantation)en_US
dc.contributor.scopusid35612977100tr_TR
dc.contributor.scopusid6701485882tr_TR
dc.contributor.scopusid12040285800tr_TR
dc.subject.scopusGlycosylated Albumin; Peritoneal Dialysis; Hemodialysisen_US
dc.subject.emtreeLong acting drugen_US
dc.subject.emtreeIsophane insulinen_US
dc.subject.emtreeInsulin lisproen_US
dc.subject.emtreeInsulin glargineen_US
dc.subject.emtreeInsulin derivativeen_US
dc.subject.emtreeHemoglobin A1cen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeNon insulin dependent diabetes mellitusen_US
dc.subject.emtreeLetteren_US
dc.subject.emtreeKidney failureen_US
dc.subject.emtreeInsulin treatmenten_US
dc.subject.emtreeHypoglycemiaen_US
dc.subject.emtreeHyperinsulinemiaen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHemodialysisen_US
dc.subject.emtreeGlucose homeostasisen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeDrug dose regimenen_US
dc.subject.emtreeDrug costen_US
dc.subject.emtreeClinical featureen_US
dc.subject.emtreeCase reporten_US
dc.subject.emtreeAdulten_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons